Correlation Between NLS Pharmaceutics and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both NLS Pharmaceutics and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NLS Pharmaceutics and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NLS Pharmaceutics AG and Mereo BioPharma Group, you can compare the effects of market volatilities on NLS Pharmaceutics and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NLS Pharmaceutics with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NLS Pharmaceutics and Mereo BioPharma.
Diversification Opportunities for NLS Pharmaceutics and Mereo BioPharma
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between NLS and Mereo is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and NLS Pharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NLS Pharmaceutics AG are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of NLS Pharmaceutics i.e., NLS Pharmaceutics and Mereo BioPharma go up and down completely randomly.
Pair Corralation between NLS Pharmaceutics and Mereo BioPharma
Given the investment horizon of 90 days NLS Pharmaceutics AG is expected to under-perform the Mereo BioPharma. In addition to that, NLS Pharmaceutics is 1.9 times more volatile than Mereo BioPharma Group. It trades about -0.1 of its total potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.15 per unit of volatility. If you would invest 420.00 in Mereo BioPharma Group on August 27, 2024 and sell it today you would lose (48.00) from holding Mereo BioPharma Group or give up 11.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NLS Pharmaceutics AG vs. Mereo BioPharma Group
Performance |
| Timeline |
| NLS Pharmaceutics |
| Mereo BioPharma Group |
NLS Pharmaceutics and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NLS Pharmaceutics and Mereo BioPharma
The main advantage of trading using opposite NLS Pharmaceutics and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NLS Pharmaceutics position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| NLS Pharmaceutics vs. Eliem Therapeutics | NLS Pharmaceutics vs. HCW Biologics | NLS Pharmaceutics vs. Scpharmaceuticals | NLS Pharmaceutics vs. Milestone Pharmaceuticals |
| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |